Immuno-psychiatry: an agenda for clinical practice and innovative research

Abstract : AbstractBackgroundThe diagnostic scheme for psychiatric disorders is currently based purely on descriptive nomenclature given that biomarkers subtypes and clearly defined causal mechanisms are lacking for the vast majority of disorders. The emerging field of “immuno-psychiatry” has the potential to widen the exploration of a mechanism-based nosology, possibly leading to the discovery of more effective personalised treatment strategies.DiscussionDisturbances in immuno-inflammatory and related systems have been implicated in the aetiology, pathophysiology, phenomenology and comorbidity of several psychiatric disorders, including major mood disorders and schizophrenia. A fundamental challenge in their clinical management is to identify bio-signatures that might indicate risk, state, trait, prognosis or theragnosis. Here, we provide the rationale for a clinical and research agenda to refine future clinical practice and conceptual views, and to delineate pathways toward innovative treatment discovery.ConclusionThe development of bio-signatures will allow clinicians to tailor interventions to the abovementioned biomarker subtypes – a major translational goal for research in this field.
Type de document :
Article dans une revue
BMC Medicine, BioMed Central, 2016, 14 (1), pp.173. 〈10.1186/s12916-016-0712-5〉
Liste complète des métadonnées

Littérature citée [72 références]  Voir  Masquer  Télécharger
Contributeur : Bmc Bmc <>
Soumis le : vendredi 28 octobre 2016 - 08:03:04
Dernière modification le : vendredi 15 février 2019 - 13:58:19


Publication financée par une institution




Marion Leboyer, Michael Berk, Robert Yolken, Ryad Tamouza, David Kupfer, et al.. Immuno-psychiatry: an agenda for clinical practice and innovative research. BMC Medicine, BioMed Central, 2016, 14 (1), pp.173. 〈10.1186/s12916-016-0712-5〉. 〈inserm-01389129〉



Consultations de la notice


Téléchargements de fichiers